Search

everythinglearnresearchcommunity

for

Search:↓

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

Scalp flaps are stiffer than skin from other body areas, which helps in planning reconstructive and cosmetic head surgeries.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The most common skin condition at the Baqai Institute in Karachi was scabies, and eczema was the most prevalent group of diseases.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Certain DNA variants can predict straight hair in Europeans but are not highly specific.

Men with androgenic alopecia have different hair copper levels than those without.

Cyclosporin doesn't stop hair loss.

LLLT is a safe, promising hair loss treatment, but more research needed.

25% of women in North Sudan have traction alopecia, linked to family history and hair treatments, highlighting the need for better hair care awareness.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Platelet-Rich Plasma (PRP) shows promise for hair growth and skin improvement in aesthetic surgery.